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Abstract
Background: Global crises inevitably increase levels of anxiety in postpartum populations. Effective and efficient
measurement is therefore essential. This study aimed to create a 12-item research short form of the 51-item
Postpartum Specific Anxiety Scale [PSAS] and validate it for use in rapid response research at a time of global crises
[PSAS-RSF-C]. We also present the same 12-items, in five other languages (Italian, French, Chinese, Spanish, Dutch)
to increase global accessibility of a psychometric tool to assess maternal mental health.
Methods: Twelve items from the PSAS were selected on the basis of a review of their factor loadings. An on-line
sample of UK mothers (N = 710) of infants up to 12 weeks old completed the PSAS-RSF-C during COVID-19
‘lockdown’.
Results: Principal component analyses on a randomly split sample (n = 344) revealed four factors, identical in
nature to the original PSAS, which in combination explained 75% of the total variance. Confirmatory factor analyses
(n = 366) demonstrated the four-factor model fit the data well. Reliability of the overall scale and of the underlying
factors in both samples proved excellent.
Conclusions: Findings suggest the PSAS-RSF-C may prove useful as a clinical screening tool and is the first
postpartum-specific psychometric scale to be validated during the COVID-19 pandemic. This offers psychometrically
sound assessment of postpartum anxiety. By increasing the accessibility of the PSAS, we aim to enable researchers
the opportunity to measure maternal anxiety, rapidly, at times of global crisis.
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Background
The COVID-19 global pandemic context
The Coronavirus [SARS-CoV-2] or COVID-19 pan-
demic poses a devastating risk to the health of the global
population. Amongst those thought to be most vulner-
able are pregnant women and newborn infants, although
guidance rapidly changed to state that pregnant women
are no more vulnerable than the general population [1].
Although the growing body of evidence remains conflict-
ing about the size of the risk to these populations, peri-
natal deaths have been reported [2]. This makes the
perinatal period a time of increased vulnerability [3].
Whilst COVID-19 poses a serious physical health risk to
those who contract the virus, there is evidence for it also
affecting mental health outcomes [4, 5]. Poor mental
health in relation to COVID-19 has been associated with
various Government mandated restrictions, which have
been enforced in an attempt to slow the spread of the
virus. These include ‘quarantine’ (the enforced isolation
of persons with or suspected of having the virus) [6];
‘social distancing’ (the physical separation of persons
outside of those in one’s family) [7]; ‘lockdown’ (the
closure of public venues and banning of non-essential
travel) [8]; and ‘shielding’ (where the most vulnerable –
including pregnant women – are advised to remain at
home and leave under no circumstances) [1]. Given the
expected effect of the COVID-19 pandemic on mental
health coupled with pregnant women and newborn
infants being labelled as vulnerable groups [1], it is
important to assess and understand the mental health
effects in perinatal women [9]. During normal circum-
stances, approximately 20% of all women who give birth
are thought to experience mental health problems [10].
The global pandemic is set to pose “unprecedented
challenges that can significantly impact on women’s men-
tal health” during the perinatal period [3], hence poten-
tially driving these numbers even higher.
Postpartum anxiety
In 2014, the National Institute of Health and Care
Excellence [NICE] requested attention to the under-
detection of postpartum anxiety in recognition of the
significant burden it poses [11]. Postpartum anxiety is
associated with many negative maternal and infant out-
comes including reduced breastfeeding [12], reduced
maternal sensitivity [13], impaired bonding [14], difficult
infant temperament [15], atypical neurodevelopment
[16], and child emotional and behavioural problems [17].
However, general measures of anxiety are relied upon in
a large majority of studies examining postpartum
anxiety, but are psychometrically problematic [11, 18].
The Postpartum Specific Anxiety Scale [PSAS] exam-
ines the frequency of maternal and infant focused anxie-
ties experienced by women across the first year of their
infants’ life [19]. The 51-item measure assesses four do-
mains of anxiety, specific to the postpartum period. Fac-
tor 1 (Maternal Competence and Attachment Anxieties)
contains 15-items which address anxieties relating to
maternal self-efficacy, parenting competence, and the
mother-infant relationship. Factor 2 (Infant Safety and
Welfare Anxieties) has 11-items which relate to fears
about infant illnesses, accidents, and cot death. Factor 3
(Practical Infant Care Anxieties) includes 7-items cover-
ing anxieties which are specific to infant care such as
feeding, sleeping, and general routine. Finally, Factor 4
(Psychosocial Adjustment to Motherhood) contains 18-
items which address adjustment concerns since the birth
of the baby about management of personal appearance,
relationships and support, work and finances, and sleep.
Each answer is given a score of between 1 and 4 with
the maximum score being a total of 204. Initial valid-
ation of the English-language version demonstrated a
score of 112 or above may be indicative of a clinical level
of anxiety [19].
The predictive validity of the measure has been exam-
ined and confirmed in relation to infant feeding out-
comes and behaviours [20], and maternal bonding
behaviours [21]. Across both of these studies, the PSAS
demonstrated stronger predictive power than a general
non-childbearing measure of anxiety.
To date, initial validity and reliability has been demon-
strated in one large UK sample [19], and more recently
two Turkish samples [22, 23]. The English-language
PSAS is currently being used throughout the UK,
Canada, Australia, Ireland, Rwanda, and the USA. Trans-
lation of the PSAS has taken place in Italy, France,
China, Spain, and The Netherlands, but are, as yet,
unpublished. Further translations are currently ongoing
in Brazil, Egypt, Germany, Greece, India, Indonesia, Iran,
Iraq, Jordan, Malaysia, Portugal, and The Philippines. A
further translation into Burmese (the language of
Myanmar) is being undertaken by a research team in
Thailand. (See Fig. 1).
Study rationale
Research to understand the psychological impact of COVID-
19 in perinatal populations is critical in mitigating the sever-
ity of the outbreak. Rapid progress in addressing this pan-
demic depends upon a coherent and integrated response
from researchers [24]. There have also been global calls for
the mental health sciences to work in a multi-disciplinary
fashion to address the possible mental health crisis which
may follow the physical health pandemic [25], and where
possible make addressing mental health needs an integral
part of the COVID-19 response [26]. The 51-items in the
PSAS take approximately 10 min for mothers to complete
which, when integrated into a survey containing a battery of
psychometric scales, may be burdensome, especially during
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the current pandemic, where specific populations may be
over-sampled. Therefore, during times of crises such as the
current COVID-19 global pandemic, it is desirable to use
shortened measures, to reduce participant burden. Further-
more, to the authors’ knowledge, there have been no psycho-
metric scales (including measures of perinatal mental health)
validated for use during the current pandemic.
In the UK, NICE guidelines recommend psychometric
measures should contain fewer than 12 items for optimal
accessibility [11]. This article reports the development of
a 12-item research short-form of the PSAS, validated for
use in global crises [PSAS-RSF-C]. The validation of the
PSAS-RSF-C, in English, acts as a nested psychometric
study within a larger on-line UK survey: PRegnancy and
Motherhood during COVID-19 [The PRaM Study]. As
the 51-item PSAS is currently undergoing multiple
translations (all at various stages of validation), we also
present, within this paper, the same 12 items, in five
other languages (Italian, French, Chinese, Spanish, and
Dutch). By increasing the accessibility of the PSAS, vali-
dated for use during COVID-19, we aim to enable
researchers the opportunity to measure maternal
anxiety, rapidly and accurately, at times of global crisis.
Methods
Participants
A UK sample of mothers (N = 710) with infants aged
between birth and 12 weeks were recruited to complete
an on-line survey. All data were collected from partici-
pants during the period of time in which the UK Gov-
ernment implemented the initial form of social
‘lockdown’ (23 March 2020–10 May 2020).
Maternal- and infant-related demographic questions were
asked at the beginning of the survey (Table 1). Specific ques-
tions were also asked on the incidence of COVID-19 in the
mother and any family members. Maternal age ranged
between 18 and 46 years (M= 31.69, SD= 5.15) and infant
age ranged between birth and 12 weeks (M= 7.92, SD=
3.67). Women were predominantly white (95%), married
(57%), university educated (64%), and professionals (52%). In
addition, 140 women had a clinical diagnosis of anxiety
(20%); 85 had a clinical diagnosis of depression (12%); and
28 had a clinical diagnosis of PTSD (4%). Forty-nine women
believed they had COVID-19 (7%), with two of these women
having been tested. Additionally, 125 women believed a fam-
ily member had COVID-19 (18%), with ten of these women
reporting their family member had been tested. Finally, 242
women believed their birth experience had been affected by
UK Government ‘lockdown’ restrictions (34%).
Design and procedure
Participants were recruited through on-line social media
platforms via an advertisement providing a link to the
Qualtrics survey platform. Prior to the main survey, an
electronic information sheet and consent form were pro-
vided with a tick box to confirm consent. Upon
Fig. 1 PSAS Reach. Key: Countries where the PSAS is being translated and/or used in research. Countries where the PSAS was already
translated and/or in use for research, and who also developed PSAS-RSF-C translations
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Table 1 Maternal, Infant, and COVID-19 Characteristics (N = 710 Mothers)
Maternal age (mean years ± SD) 31.69
(5.15)
Maternal Diagnoses Value n
(%)
Infant age (mean weeks ± SD) 7.92 (3.67) Current Diagnosis of Anxiety Mode of delivery
Yes 140 (19.7) Vaginal (without medical
intervention)
359 (50.6)
Maternal Characteristic Value n
(%)
No 567 (79.9) Elective caesarean section 134 (18.9)
Ethnicity Prefer not to say 3 (0.4) Emergency caesarean section 136 (19.2)
White 676 (95.2) Vaginal birth (assisted delivery) 81 (11.4)
Pakistani 2 (0.3) Current Diagnosis of Depression
Black African 2 (0.3) Yes 85 (12.0) Multiple birth
Black Caribbean 1 (0.1) No 621 (87.5) Yes 9 (1.3)
Chinese 3 (0.4) Prefer not to say 4 (0.6) No 701 (98.7)
Indian 7 (1.0)
Black Other 1 (0.1) Current Diagnosis of PTSD Infant medical complications since birth
Other or prefer not to say 18 (2.5) Yes 28 (3.9) Yes 161 (22.7)
No 676 (95.2) No 546 (76.9)
Marital Status Prefer not to say 6 (0.8)




43 (6.1) Postpartum Anxiety (PPA) Value n
(%)
Suspected COVID-19





Occupationa No 660 (93.0)
In paid employment 633 (89.2) Feeling that PPA has been affected by COVID-19 Prefer not to say 1 (0.1)
Not in paid employment 77 (10.8) Yes 438 (61.7)
No 267 (37.6) Tested for COVID-19
Education Attainment Prefer not to say 5 (0.7) Yes 2 (0.3)
University-level education 455 (64.1) No 47 (6.6)
School-level education 230 (32.4) PPA affected by COVID-19 Mean (±
SD)b
7.33 (1.82) Not Applicable 661 (93.1)
No qualifications 10 (1.4)
Other qualification 15 (2.1) Clinical anxiety diagnosis overall PSAS-RSF-C
Mean (± SD)





Living Status No 23.90
(5.60)
No 584 (82.3)
Own property 453 (63.8) Prefer not to say 1 (0.1)
Rent – privately (from private landlord) 147 (20.7) Infant Characteristics Value n
(%)
Rent - local authority (state-owned
housing)
63 (8.9) Timing of birth Family member tested for COVID-
19
Live with parents 36 (5.1) Premature (< 37 weeks) 54 (7.4) Yes 10 (1.4)
Other 11 (1.5) Term (≥37 to ≤42 weeks) 652 (91.8) No 115 (16.2)
Post Term (> 42 weeks) 4 (0.6) Not applicable 585 (82.4)
Household Size (incl. participant)
2 people 39 (5.5) Birth order Birth experience affected by UK Government
‘lockdown’ restrictions
Silverio et al. BMC Pregnancy and Childbirth          (2021) 21:112 Page 4 of 12
completion of the survey, participants were provided
with a full electronic debrief with signposting to relevant
support information, and were entered into a £25 prize
draw.
Instruments
Postpartum Specific Anxiety Scale – Research Short Form –
for global Crises [PSAS-RSF-C]
The original principal component analysis (PCA) pro-
vides factor loadings showing the strength of the rela-
tionship between the underlying PSAS factors and
individual items [19]. Researchers commonly use factor
loading as a scale reduction technique, preserving items
with the highest factor loading [27, 28]. In-line with
NICE guidelines [11], 12-items from the PSAS were
selected on the basis of a review of their factor loading.
The three items with the highest factor loadings (all >
0.50), were selected from each sub-scale. In the original
validation of the PSAS [19], the third and fourth items
from Factor 1 possessed identical factor loadings (0.66).
In-line with guidelines for psychometric scale develop-
ment [28, 29], Item 3 was selected over Item 4 for the
PSAS-RSF-C, as it provided Factor 1 with a more com-
prehensive assessment of Maternal Competence and
Attachment Anxieties. The final 12-items of the English-
language PSAS-RSF-C can be found in Table 2.
Edinburgh Postnatal Depression Scale [EPDS]
The EPDS [30] is a 10-item self-report questionnaire
which screens for postnatal depressive symptomatology.
It is commonly utilised and recommended screening
scale for postnatal depression. Scored out of 30, higher
levels of postpartum depressive symptoms are indicated
by high scores on the scale, with a score of greater than
10 indicative of a probable postpartum depression. Items
three, four, and five cluster on an anxiety factor [EPDS-
3A] to indicate postpartum anxiety [31, 32]. Scored out
of nine, with scores of six or above indicating probable
postpartum anxiety.
State-Trait Anxiety Inventory – State scale [STAI-S]
The STAI-S is a sub-scale of the STAI [33]. It is a 20-
item self-report questionnaire which measures situ-
ational anxiety. The STAI-S is a valid and reliable meas-
ure used frequently in perinatal samples of women [18].
It is scored out of 80, on a four point Likert scale, with
higher scores indicating higher levels of anxiety.
Parenting Sense of Competence scale [PSoC]
The PSoC is a frequently used measure of parenting
competence, with seven items and two sub-scales [34].
Each item is rated on a six-point Likert scale with higher
scores indicating a higher sense of parenting
competence.
Method of analysis
Data taken from The UK PRaM Study (N = 710) were
randomly split into two samples: One for the exploratory
factor analysis (n = 344), the other for the confirmatory
factor analysis (n = 366).
Exploratory factor analysis (group 1; n = 344)
Due to these data being ordinal (as scored on a four-
point Likert scale), a parallel analysis was conducted
using the simulated polychoric correlation matrix in
order to identify the number of likely components in the
data. Following this, a PCA with oblique rotation (obli-
min) was conducted, again using the polychoric correl-
ation matrix. Notably, results were identical when the
raw data were analysed.
Confirmatory factor analysis (group 2; n = 366)
A confirmatory factor analysis was performed using
MPLUS version 8.4 [35], using robust unweighted least
squares estimation [36]. Items were free to load onto
their corresponding latent factors, and latent factors
were free to correlate with each other. Model fit was
assessed using the Comparative Fit Index [CFI] and the
Tucker-Lewis Index [TLI], where values of above .90 are
deemed ‘acceptable’, and values above .95 are deemed
‘good’. The Root Mean Square Error of Approximation
(RMSEA) [37] indicates a good fit (<.05), a fair fit (.05
<> .08), a mediocre fit (.08 <> .10), and a poor fit (>.10).
The Standardized Root Mean Square Residual [SRMR] is
considered a good fit where values are less than .08 [38].
Modification indices were also inspected, and if in excess
of 20, covariance pathways were added between error
terms (if conceptually appropriate, items loaded onto the
same factor).
Table 1 Maternal, Infant, and COVID-19 Characteristics (N = 710 Mothers) (Continued)
3 people 296 (41.7) 1st 351 (49.4) Yes 242 (34.1)
4 people 260 (36.6) 2nd 265 (37.3) No 464 (65.4)
5 or more people 115 (16.2) 3rd and after 93 (13.1) Prefer not to say 4 (0.6)
Prefer not to say 1 (0.1)
aParticipants provided answers to the question: ‘What is your occupation? (If you are currently on maternity leave, what was your occupation prior to this)’
bWomen who answered ‘Yes’ to their feelings of PPA being affected by COVID-19, were then asked to rate on a scale of 1–10 (whereby 1 =much less anxious to
10 =much more anxious) of how much they felt their feelings had been affected
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my baby was born.
Mi sono preoccupata di
più del rapporto con il
mio partner rispetto a
prima che il mio
bambino nascesse.
Je me suis davantage
inquiétée de ma relation
avec mon partenaire











Ik heb me meer zorgen
gemaakt over mijn
relatie met mijn partner
dan voordat mijn baby
was geboren.
2. I have worried about
my baby’s weight.
Mi sono preoccupata
per il peso del mio
bambino.
Je me suis inquiétée du
poids de mon bébé.
Me preocupa el
peso de mi bebé.
我担心宝宝
的体重
Ik heb me zorgen
gemaakt over het
gewicht van mijn baby.
3. I have worried about
getting my baby into
a routine.
Mi sono preoccupata di
far avere al mio
bambino una sua
routine.
Je me suis inquiétée
d’arriver à instaurer une







Ik heb me zorgen
gemaakt over het
krijgen van een routine
voor mijn baby.
















alguien o algo, por
accidente, haga





Ik heb me zorgen
gemaakt dat mijn baby
per ongeluk bezeerd
raakt door iets of
iemand anders.
5. I have felt
unconfident or
incapable of meeting
my baby’s basic care
needs.
Mi sono sentita insicura
o incapace di soddisfare
i bisogni primari del mio
bambino.
Je me suis sentie pas


























relazione con il mio
bambino.
J’ai eu des pensées
négatives concernant ma












de relatie die ik met
mijn baby heb.




per la quantità di latte
assunta dal mio
bambino.
Je me suis inquiétée de












8. I have worried that
my baby will stop
breathing while
sleeping.
Ho avuto paura che il
mio bambino smettesse
di respirare durante il
sonno.
J’ai craint que mon bébé
ne cesse de respirer
pendant son sommeil.
Me preocupa que






Ik heb me zorgen




9. I have felt that my
baby would be
better cared for by
someone else.




J’ai senti que quelqu’un
d’autre prendrait mieux
soin de mon bébé.







Ik heb het gevoel gehad
dat mijn baby beter zou
worden verzorgd door
iemand anders.




nei confronti del mio
partner.







Ik heb gevoelens van
wrok gehad naar mijn
partner.







Je suis allée surveiller de









Ik heb herhaaldelijk mijn
slapende baby
gecontroleerd.
12. I have felt tired even
after a good amount
of rest.
Mi sono sentita stanca
anche dopo una buona
quantità di riposo.










Ik heb me moe gevoeld,
zelfs na een goede
hoeveelheid rust.
aIndicates items which may not be applicable to all mothers’ circumstances and therefore can be left blank by the participant
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Internal consistency
Internal reliability of the full scale and each subscale was
estimated by computing McDonald’s ω through the
polychoric correlation matrix. This was computed for
both data sets.
Convergent validity
Correlation analyses were performed to examine the
associations between the PSAS-RSF-C and theoretically
related measures of anxiety (i.e. EPDS-A; STAI-S),
depression (i.e. EPDS), and parenting competence (i.e.
PSoC).
Preliminary screening accuracy
A receiver operating characteristic [ROC] analysis was
undertaken to distinguish between those with and with-
out a self-reported current clinical diagnosis of anxiety.
Results
Factor structure of the PSAS-RSF-C
The factor structure of the PSAS-RSF-C (Table 3)
was examined using data from all the participants in
Group 1 (n = 344). The parallel analysis suggested
there were four factors which are consistent with the
original 51-item measure. Sampling adequacy for the
12-item scale was excellent (Kaiser-Meyer-Olkin;
KMO = 0.80) and Bartlett’s test of sphericity demon-
strated correlations between items were large enough
for PCA (χ2 (66) = 284.17, p < .001). The PCA revealed
four factors, which in combination explained 75% of
the total variance. The UK-based PSAS Working
Group [VF, SAS, JAH, JCGH, SMD, PaCh] conducted
a theoretical review of the factor loadings after
oblique (direct oblimin) rotation, which revealed that
the factor structure of the PSAS-RSF-C was identical
in nature to that of the original PSAS. Three items
loaded onto each of the four factors which they
belonged to in the long form: Maternal Competence
and Attachment Anxieties; Infant Safety and Welfare
Anxieties; Practical Infant Care Anxieties; and Psycho-
social Adjustment to Motherhood. The four factors
had good reliability, with McDonald’s ω ranging from
.74 to .88 (see Table 3). Furthermore, the overall scale
had good reliability (McDonald’s ω = .87).
Confirmation of factor structure
The initial model was a moderate to good fit of the data
(CFI = .928, TLI = .901, RMSEA = .096, SRMR = .067).
Modification indices indicated a covariance should be
added between three pairs of residuals (Fig. 2). As a
result, the model fit improved (CFI = .973, TLI = .960,
RMSEA =. 055, SRMR = .045). All items significantly
loaded onto each factor (p < .001; see Fig. 2 for the stan-
dardised factor loadings). The overall scale retained good
reliability (McDonald’s ω = .87).
Table 3 Factor structure of the PSAS-RSF-C
Rotated components
Scale item 1 2 3 4
Factor 1: Maternal Competence and Attachment Anxieties
1. I have had negative thoughts about the relationship with my baby 0.85 −0.02 −0.01 0.13
2.I have felt that my baby would be better cared for by someone else 0.85 0.04 0.06 0.04
3.I have felt unconfident or incapable of meeting my baby’s basic care needs 0.76 0.03 0.25 0.01
Factor 2: Infant Safety and Welfare Anxieties
4. I have worried about my baby being accidentally harmed by someone or something else 0.40 0.69 −0.06 −0.05
5. I have repeatedly checked on my sleeping baby −0.26 0.86 0.14 0.08
6. I have worried that my baby will stop breathing while sleeping 0.09 0.91 −0.03 0.00
Factor 3: Practical Infant Care Anxieties
7. I have worried about my baby’s milk intake 0.11 0.06 0.86 −0.03
8. I have worried about my baby’s weight 0.00 0.00 0.92 0.01
9. I have worried about getting my baby into a routine 0.28 −0.04 0.51 0.19
Factor 4: Psychosocial Adjustment to Motherhood
10. I have felt resentment towards my partner 0.17 0.04 −0.19 0.80
11. I have felt tired even after a good amount of rest −0.16 0.11 0.21 0.68
12. I have worried more about my relationship with my partner than before my baby was born 0.03 −0.05 0.06 0.84
% of variance explained 22 18 18 17
McDonald’s Omega .88 .83 .82 .74
All significant loadings in bold
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Convergent validity
The participants who completed all convergent measures
were included in these analyses. The PSAS-RSF-C total
score was significantly correlated with theoretically
related measures of anxiety (i.e. EPDS-A [n = 710];
STAI-S [n = 709]), depression (i.e. EPDS [n = 710]), and
parenting competence (i.e. PSoC [n = 666]) indicating
good convergent validity (Table 4).
Preliminary screening accuracy of PSAS-RSF-C
First, An independent samples t-test demonstrated
that the mean PSAS-RSF-C scores for those with a
self-reported clinical diagnosis of anxiety (n = 140;
M = 28.35; SD = 7.45) were significantly higher than
those without a self-reported clinical diagnosis (n =
567; M = 23.93; SD = 5.60) t (705) = − 7.79; p < .001.
Then, to preliminarily evaluate the performance of
the PSAS-RSF-C in distinguishing between those with
or without a current clinical diagnosis of anxiety, a
Receiver Operating Characteristic [ROC] analysis was
conducted. A statistically significant ROC curve
(AUC = .68; SE = .03; p < .001; 95% CI .62 to .73)
revealed the optimal cut-off PSAS-RSF-C score for
detecting clinical levels of anxiety was 26 out of a
total of 48 with a sensitivity and specificity of .62 and
.64, respectively (Fig. 3).
International use of the PSAS-RSF-C
Translation of the PSAS follows traditional methods of
psychometric scale translation [39–42]. In brief, this re-
quires at least three researchers to supply separate ver-
sions of the PSAS into the desired language. These
translations are then given to an independent back-
translator [39], who is unfamiliar with the PSAS. The
back-translator will select the most eloquent translation
of each item from the three translated versions [40].
Fig. 2 Standardised Factor Loadings
Table 4 Pearson product-moment correlations demonstrating
convergent validity between the PSAS-RSF-C and other
validated measures of maternal mental health
EPDS-A STAI-S EPDS PSoC
PSAS-RSF-C .57* .62* 0.67* −0.54*
*p < .001 (one-tailed)
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This single back-translation is then checked with the
UK-based PSAS Working Group, who checks the back-
translation against the original PSAS for inconsistencies
and intended meaning [41]. The items which make up
this final back-translated version are the items which will
be used for the final translated version. Inconsistencies
at any stage of the translation process are discussed
amongst the translating team, with irreconcilable dis-
crepancies being referred to the UK-based PSAS Work-
ing Group [42].
We therefore have selected the same 12-items in the
currently unvalidated, but translated Italian, French,
Spanish, Chinese, and Dutch versions of the 51-item
PSAS to form a PSAS-RSF-C for each country (PSAS-
IT-RSF-C, PSAS-FR-RSF-C, PSAS-CN-RSF-C, PSAS-ES-
RSF-C, and PSAS-NL-RSF-C, respectively, Table 2).
Discussion
The primary aim of the current study was to develop a
brief and accessible measure of postpartum anxiety. We
aimed to validate the tool for research use in global cri-
ses such as the current pandemic, and further explore its
scope for clinical usage. To that end, we developed a 12-
item short-form of the English-language PSAS and ex-
amined the psychometric properties and diagnostic ac-
curacy of the measure in two samples of women during
the UK ‘lockdown’.
The selection of items for the short-form was in-
formed by the aim of preserving the originally pro-
posed four factor structure of the PSAS [19] with
domains of both maternal- and infant-focused anxiety.
This was in order to maintain breadth of content
coverage, in-line with psychometric guidance [27–29].
The validation of the English-language PSAS-RSF-C
shows promising psychometric properties which
would be useful for rapid measurement of maternal
anxiety in the current global crisis, and any crises
which may occur in the future.
The current findings demonstrate the robustness of
the PSAS across diverse psycho-social contexts. Explora-
tory factor analyses in one sample demonstrated a
simple four-factor structure, identical to the original 51-
item version [19], expressed as (1) Competence and
Attachment Anxieties; (2) Infant Safety and Welfare
Anxieties; (3) Practical Baby Care Anxieties; and (4) Psy-
chosocial Adjustment to Motherhood. Confirmatory fac-
tor analyses in a second sample demonstrated an
excellent fit of the measurement model. The overall
PSAS-RSF-C and its sub-scales demonstrated good reli-
ability in both samples. This suggests the types of anxie-
ties new mothers are experiencing during the current
crisis are comparable to those which occurred pre-
pandemic, and are maternal- and infant-focused in na-
ture. This indicates a continued critical need to further
understand the experience and impact of perinatal
anxiety during the current crisis [3, 43–45].
The diagnostic accuracy of the original 51-item PSAS
to detect individuals with self-reported diagnosis of
anxiety was examined by means of ROC analyses [19].
To our knowledge, there are no other measures of anx-
iety validated during the current global COVID-19 pan-
demic, with which to compare these findings. However,
when compared to the original 51-item PSAS, the results
of this study indicate a good and comparably good diag-
nostic accuracy for the PSAS-RSF-C. We envisage the
PSAS-RSF-C can be applied to a clinical setting to assist
healthcare professionals in identifying mothers with
problematic anxiety, as part of a broader clinical assess-
ment. Therefore, we propose a cut-off score of 26 which
provides a good balance between the sensitivity and spe-
cificity of the tool [46]. However, we recognise mental
health may be elevated during the current pandemic [3–
6, 8, 9, 26], and as such, clinical judgement should be
used in parallel with PSAS-RSF-C scores.
The translated versions of the PSAS-RSF-C into five
global languages (Italian, French, Chinese, Spanish, and
Dutch) will enable a broad use of the tool in order for
researchers and clinicians globally to assess maternal
mental health when undertaking rapid response research
and clinical assessments during the pandemic. Whilst
each translation requires subsequent validation, work is
already underway to do so. This will allow for a more
comprehensive assessment of global maternal mental
health during the COVID-19 pandemic, as well as
Fig. 3 Receiver Operating Characteristic [ROC] curve analysis. Area
under the curve = 0.68
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providing the opportunity to compare between datasets
utilising the same scale items, in different languages.
Strengths, limitations, and future directions
A major strength of this study is that, to the authors’
knowledge, this is the first postpartum-specific psy-
chometric scale to be validated for use during the
COVID-19 global pandemic, and in being so, is also
one of the first perinatal psychometric tools to be val-
idated in the current crisis, with others including the
Pandemic-Related Pregnancy Stress Scale [47]. This
means postpartum anxiety can be effectively measured
during this pandemic, and similar global crises in the
future. Furthermore, many psychometric studies in-
appropriately use factor analyses developed for
interval-level data, when the psychological construct,
and the measurement of it, is, in fact, ordinal in na-
ture. A strength of this study is the use of a polycho-
ric correlation matrix, which overcomes this common,
but often statistically inappropriate practice [48]. Add-
itionally, we report McDonald’s Omega, to appraise
reliability, as opposed to Cronbach’s Alpha, which
focuses on the greatest lower bounds estimate [49].
Finally, providing a validated 12-item research short-
form of the PSAS means it can be more readily
adopted into studies containing a large battery of
tests during COVID-19 and other such global crises,
without being prohibitively long. Whilst the diagnostic
accuracy was found to be good in this validation
study, we recommend erring on the side of caution
when making clinical decisions based on this research
short-form alone.
A limitation is the use of an on-line convenience sam-
ple. This recruitment, whilst pragmatic for the rapid
response nature of this research, lacked sampling con-
trol. The sample were predominantly white, married
women, with university education and professional occu-
pations. There was also a high proportion of assisted
vaginal births and caesarean sections, and whilst the
cause of this remains unknown, it has been suggested
women have delayed seeking care during the pandemic,
leading to higher incidence rates of obstetric complica-
tions [50]. The psychometric properties of the PSAS-
RSF-C may, therefore, vary in other populations and it
should be subject to replication studies using diverse
samples.
Future research efforts should be directed towards the
global validation of the PSAS and the PSAS-RSF-C.
Whilst the five translations of the PSAS-RSF-C pre-
sented in this paper have not yet been subjected to valid-
ation studies, validation work must be conducted to
ensure the validity and reliability of both the 12-item
PSAS-RSF-C and the 51-item PSAS in other languages.
Previous work examining the predictive validity of the
PSAS [20, 22] consistently finds it is a more powerful
predictor of perinatal outcomes than a general measure
(e.g. STAI [33]). Consequently, this tool would be useful
in longitudinal studies aiming to better understand the
persistent mental health impact of the pandemic (and
other such global crises in the future) on maternal and
infant outcomes. Preliminary work demonstrates the
sub-scales of the PSAS have differential effects on mater-
nal and infant outcomes [51]. Further investigations of
the sub-scales could provide greater level of detail in
terms of identifying specific risk factors and mechanisms
of PPA and may offer opportunities for targeted
intervention.
Conclusion
Following the calls for mental health to be addressed
during and after the global crisis, the PSAS-RSF-C offers
one way in which to reliably measure maternal mental
health in the postpartum period. To the best of the
authors’ knowledge, this is the first postpartum-specific
psychometric scale to be validated for use during the
COVID-19 pandemic, and in being so, is also one of the
first perinatal psychometric tools to be validated during
this current crisis. In doing so, we provide opportunity
for researchers and clinicians to measure postpartum
anxiety accurately, whilst laying foundations for further
global psychometric work to be undertaken during the
current crisis, and in those which will present in the
future.
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